Correction to: Cellular & Molecular Immunology advance online publication 8 November 2010; doi:10.1038/cmi.2010.53
The html and pdf versions of this paper have been corrected. The printed version of the paper also carries the correct information.
In page 1, the reference number β19β in the line: βIn the context of transplantation, we have previously shown that over expression of IDO induces a protective effect against rejection of allergenic grafts by inhibiting alloreactive T-cell activities.17,19β has been deleted.
In page 6, the reference number β16, 18β in the line: βBecause we have previously demonstrated that IDO plays a role in allograft tolerance,16,18 we tested whether IDO is essential for the protection of skin allografts by infusion of donor-derived SSCs.β has been changed to β17, 19β.
Figure 7a in the above paper appeared incorrectly. One asterisk in the graph in Figure 7a is missing. The correct graph, which is shown as below, has been used to replace the incorrect one.
The content of reference 24 has been changed to: Munn DH, Sharma MD, Hou D, Baban B, Lee JR, Antonia SJ et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 2004; 114: 280β290.
The content of reference 25 has been changed to: Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007; 7: 610β621.
The editorial office would like to apologize for the mistakes.
Additional information
The online version of the original article can be found at 10.1038/cmi.2010.53
Rights and permissions
About this article
Cite this article
Liu, L., Duan, L., Gong, M. et al. Erratum: Indoleamine 2,3-dioxygenase and regulatory dendritic cells contribute to the allograft protection induced by infusion of donor-specific splenic stromal cells. Cell Mol Immunol 8, 92 (2011). https://doi.org/10.1038/cmi.2010.61
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2010.61